Literature DB >> 1308387

Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous system.

O Perrella1, M Guerriero, E Izzo, M Soscia, P B Carrieri.   

Abstract

We detected the cytokines interleukin-6 (IL-6) and granulocyte macrophage-CSF (GM-CSF) by ELISA in the CSF and serum of 30 HIV-infected patients classified as AIDS dementia complex (ADC), and 20 subjects with other neurological diseases (OND). We have found a high incidence of detectable IL-6 and GM-CSF in the CSF of ADC patients compared with OND patients. No statistical differences were observed between both groups for serum IL-6 and GM-CSF levels. These results suggest an intrathecal synthesis of these cytokines and a possible involvement in the pathogenesis of ADC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1308387     DOI: 10.1590/s0004-282x1992000200008

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  14 in total

1.  PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation.

Authors:  Toni K Roberts; Eliseo A Eugenin; Susan Morgello; Janice E Clements; M Christine Zink; Joan W Berman
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.

Authors:  Stephanie J Bissel; Julia Kofler; Julia Nyaundi; Michael Murphey-Corb; Stephen R Wisniewski; Clayton A Wiley
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-08       Impact factor: 4.147

3.  HIV-1 Tat promotes astrocytic release of CCL2 through MMP/PAR-1 signaling.

Authors:  P Lorenzo Bozzelli; Tao Yin; Valeria Avdoshina; Italo Mocchetti; Katherine E Conant; Kathleen A Maguire-Zeiss
Journal:  Glia       Date:  2019-05-23       Impact factor: 7.452

4.  Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection.

Authors:  Rick B Meeker; Winona Poulton; Silva Markovic-Plese; Colin Hall; Kevin Robertson
Journal:  J Neurovirol       Date:  2011-05-10       Impact factor: 2.643

5.  Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.

Authors:  Ned Sacktor; David R Boulware; Mahsa Abassi; Bozena M Morawski; Gertrude Nakigozi; Noeline Nakasujja; Xiangrong Kong; David B Meya; Kevin Robertson; Ronald Gray; Maria J Wawer
Journal:  J Neurovirol       Date:  2016-12-19       Impact factor: 2.643

6.  Increased in vivo activation of microglia and astrocytes in the brains of mice transgenic for an infectious R5 human immunodeficiency virus type 1 provirus and for CD4-specific expression of human cyclin T1 in response to stimulation by lipopolysaccharides.

Authors:  Jinglin Sun; Jian Hua Zheng; Mengliang Zhao; Sunhee Lee; Harris Goldstein
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

Review 7.  CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.

Authors:  Anjana Yadav; Ronald G Collman
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-19       Impact factor: 4.147

8.  Estimation of virological and immunological parameters in subjects from South India infected with human immunodeficiency virus type 1 clade C and correlation of findings with occurrence of neurological disease.

Authors:  Anupa Kamat; V Ravi; Anita Desai; P Satishchandra; K S Satish; Mahendra Kumar
Journal:  J Neurovirol       Date:  2008-11-22       Impact factor: 2.643

9.  Differential ex vivo nitric oxide production by acutely isolated neonatal and adult microglia.

Authors:  John B Schell; Courtney A Crane; Michael F Smith; Margo R Roberts
Journal:  J Neuroimmunol       Date:  2007-08-15       Impact factor: 3.478

10.  Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus.

Authors:  Isabelle Bardou; Holly M Brothers; Roxanne M Kaercher; Sarah C Hopp; Gary L Wenk
Journal:  Neurobiol Aging       Date:  2013-04-30       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.